Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
August 25, 2015
Showing 131 - 140 of 146 results
JAMDA
August 19, 2015
Mild Cognitive Impairment, Slow Gait, and Risk of Disability: A Prospective Study
Mild cognitive impairment (MCI) may be a risk for disability, and co-occurrence of slow gait (SG) and MCI may increase this risk.
JAMDA
June 26, 2015
Education and Executive Function Mediate Engagement in Advance Care Planning in Early Cognitive Impairment
Advance care planning (ACP) is an important component to holistic care for people with early cognitive impairment (ECI) who are generally still mentally capable of making rational decisions. This study explores the willingness of people with ECI to engage in ACP and how clinical and behavioral variables sh...
JAMDA
February 24, 2015
Frailty Screening in the Community Using the FRAIL Scale
To explore the feasibility of using the FRAIL scale in community screening of older Chinese people aged 65 years and older, followed by clinical validation by comprehensive geriatric assessment of those classified as pre-frail or frail.
JAMDA
February 14, 2015
The Course of Neuropsychiatric Symptoms in Dementia: A 3-Year Longitudinal Study
Patients with dementia experience a wide range of neuropsychiatric symptoms. These symptoms often cause considerable distress to patients and caregivers, and often contribute to institutionalization. The current study examined the prevalence and course of neuropsychiatric symptoms in a large sample of pati...
JAMDA
December 17, 2014
SAIDO Learning as a Cognitive Intervention for Dementia Care: A Preliminary Study
The purpose of this study was to examine the beneficial effects on cognitive function by a cognitive intervention program designed for dementia care called Learning Therapy in Japan and SAIDO Learning in the United States (hereinafter “SAIDO Learning,” as appropriate). SAIDO Learning is a working memory tr...
JAMDA
December 15, 2014
A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)
Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential benefits of memant...
JAMDA
October 23, 2014
The Study of Mental and Resistance Training (SMART) Study—Resistance Training and/or Cognitive Training in Mild Cognitive Impairment: A Randomized, Double-Blind, Double-Sham Controlled Trial
Mild cognitive impairment (MCI) increases dementia risk with no pharmacologic treatment available.
JAMDA
October 10, 2014
Role of the Extended Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer DiseaseMAPTRole of the Extended Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer Disease
There is evidence that neurofibrillary tangle (NFT) burden is associated with psychotic symptoms in Alzheimer disease (AD). However, it is not clear whether this association is direct or mediated through the increased cognitive impairment associated with NFTs.
JAMDA
July 14, 2014